메뉴 건너뛰기




Volumn 16, Issue 1, 2006, Pages 63-67

Does parathyroid hormone affect erythropoietin therapy in dialysis patients?

Author keywords

Anemia; Hemodialysis; Hyperparathyroidism; Peritoneal dialysis; Recombinant human erythropoietin

Indexed keywords

ALFACALCIDOL; ALKALINE PHOSPHATASE; ANTIHYPERTENSIVE AGENT; CALCIUM; CREATININE; HEMOGLOBIN; NITROGEN; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE BINDING AGENT; RECOMBINANT ERYTHROPOIETIN; UREA; VITAMIN;

EID: 33845543455     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096143     Document Type: Article
Times cited : (17)

References (22)
  • 1
    • 0023850473 scopus 로고
    • Recombinant human erythropoietin: Implication for nephrology
    • Eschbach J, Adamson J: Recombinant human erythropoietin: implication for nephrology. Am J Kidney Dis 1988;11:203-209.
    • (1988) Am J Kidney Dis , vol.11 , pp. 203-209
    • Eschbach, J.1    Adamson, J.2
  • 2
    • 0028535168 scopus 로고
    • Monitoring of iron status and iron supplementation in patients treated with erythropoietin
    • Macdougall IC: Monitoring of iron status and iron supplementation in patients treated with erythropoietin. Curr Open Nephrol Hypertens 1994;3:620-625.
    • (1994) Curr Open Nephrol Hypertens , vol.3 , pp. 620-625
    • Macdougall, I.C.1
  • 3
    • 0025128680 scopus 로고
    • Erythropoietin, aluminum, and anemia in patients on haemodialysis
    • Rosenlof K, Fyhrquist F, Tenhunen R: Erythropoietin, aluminum, and anemia in patients on haemodialysis. Lancet 1990;335:247-249.
    • (1990) Lancet , vol.335 , pp. 247-249
    • Rosenlof, K.1    Fyhrquist, F.2    Tenhunen, R.3
  • 4
    • 7044286084 scopus 로고    scopus 로고
    • Erythropoietin resistance in patients on continuous ambulatory peritoneal dialysis
    • Nakamoto H, Kanno Y, Okada H, Suzuki H: Erythropoietin resistance in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial 2004;20:111-116.
    • (2004) Adv Perit Dial , vol.20 , pp. 111-116
    • Nakamoto, H.1    Kanno, Y.2    Okada, H.3    Suzuki, H.4
  • 5
    • 0025335062 scopus 로고
    • Occult infection and resistance of anemia to rHUEPO therapy in renal failure
    • Muirhead N, Hodsman AB: Occult infection and resistance of anemia to rHUEPO therapy in renal failure. Nephrol Dial Transplant 1990;5:232-234.
    • (1990) Nephrol Dial Transplant , vol.5 , pp. 232-234
    • Muirhead, N.1    Hodsman, A.B.2
  • 6
    • 0027533230 scopus 로고
    • Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in anemia
    • Rao DS, Shih MS, Mohini R: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in anemia. N Engl J Med 1993;328:171-175.
    • (1993) N Engl J Med , vol.328 , pp. 171-175
    • Rao, D.S.1    Shih, M.S.2    Mohini, R.3
  • 7
    • 0026046922 scopus 로고
    • Modulating factors in hematopoietic response to erythropoietin
    • Drueke TB: Modulating factors in hematopoietic response to erythropoietin. Am J Kidney Dis 1991;18:87-92.
    • (1991) Am J Kidney Dis , vol.18 , pp. 87-92
    • Drueke, T.B.1
  • 8
    • 0035228407 scopus 로고    scopus 로고
    • K/DOQI Clinical practice guidelines: Anemia of chronic kidney disease
    • National Kidney Foundation, Kidney-Dialysis Outcomes Quality Initiative
    • National Kidney Foundation, Kidney-Dialysis Outcomes Quality Initiative: K/DOQI Clinical practice guidelines: anemia of chronic kidney disease. Am J Kidney Dis 2001;37(suppl 1):S182-S238.
    • (2001) Am J Kidney Dis , vol.37 , Issue.SUPPL. 1
  • 9
    • 0000301801 scopus 로고    scopus 로고
    • K/DOQI Clinical practice guidelines for bone metabolism and disease in chronic kidney disease
    • National Kidney Foundation, Kidney-Dialysis Outcomes Quality Initiative
    • National Kidney Foundation, Kidney-Dialysis Outcomes Quality Initiative: K/DOQI Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;37(suppl 3):S182-S238.
    • (2003) Am J Kidney Dis , vol.37 , Issue.SUPPL. 3
  • 10
    • 0038355213 scopus 로고    scopus 로고
    • Infuence of relative hypoparathyroidism on the responsiveness to recombinant human erythropoietin in hemodialysis patients
    • Shih-Ping Hsu, Yu-Sen Peng, Mei-Fen Pai, Kuan-Yu Hung, Tun-jun Tsai: Infuence of relative hypoparathyroidism on the responsiveness to recombinant human erythropoietin in hemodialysis patients. Blood Purif 2003;21:220-224.
    • (2003) Blood Purif , vol.21 , pp. 220-224
    • Hsu, S.-P.1    Peng, Y.-S.2    Pai, M.-F.3    Hung, K.-Y.4    Tsai, T.-J.5
  • 11
    • 0031871948 scopus 로고    scopus 로고
    • Human parathyroid hormone does not influence human erythropoiesis in vitro
    • Komatsuda A, Hirokawa M, Haseyama T, et al: Human parathyroid hormone does not influence human erythropoiesis in vitro. Nephrol Dial Transplant 1998;13:2088-2091.
    • (1998) Nephrol Dial Transplant , vol.13 , pp. 2088-2091
    • Komatsuda, A.1    Hirokawa, M.2    Haseyama, T.3
  • 12
    • 0032943841 scopus 로고    scopus 로고
    • Acute phase response predicts erythropoietin resistance in haemodialysis and peritoneal dialysis patients
    • Gunnell J, Yeun JY, Depner TA, Kaysen GA: Acute phase response predicts erythropoietin resistance in haemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999;33:63-72.
    • (1999) Am J Kidney Dis , vol.33 , pp. 63-72
    • Gunnell, J.1    Yeun, J.Y.2    Depner, T.A.3    Kaysen, G.A.4
  • 14
    • 0019964541 scopus 로고
    • Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis
    • Zappacosta AR, Caro J, Erslev AJ: Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis. Am J Med 1982;72:53-57.
    • (1982) Am J Med , vol.72 , pp. 53-57
    • Zappacosta, A.R.1    Caro, J.2    Erslev, A.J.3
  • 15
    • 0020641691 scopus 로고
    • Influence of continuous ambulatory peritoneal dialysis on the anemia of end-stage renal disease
    • DePaepe MBJ, Schelstraete KHG, Ringoir SMG, Lameire NH: Influence of continuous ambulatory peritoneal dialysis on the anemia of end-stage renal disease. Kidney Int 1983;23:744-748.
    • (1983) Kidney Int , vol.23 , pp. 744-748
    • DePaepe, M.B.J.1    Schelstraete, K.H.G.2    Ringoir, S.M.G.3    Lameire, N.H.4
  • 18
    • 0025129476 scopus 로고
    • Efficient removal of albumin-bound furancarboxylic acid; an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis
    • Niwa T, Yazawa T, Kodoma T, Uehara Y, Maeda K, Yamada K: Efficient removal of albumin-bound furancarboxylic acid; an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis. Nephron 1990;56:241-245.
    • (1990) Nephron , vol.56 , pp. 241-245
    • Niwa, T.1    Yazawa, T.2    Kodoma, T.3    Uehara, Y.4    Maeda, K.5    Yamada, K.6
  • 19
    • 0033647569 scopus 로고    scopus 로고
    • Influence of adynamic bone disease on responsiveness to recombinant erythropoietin in peritoneal dialysis patients
    • Kcomt J, Sotelo C, Raja R: Influence of adynamic bone disease on responsiveness to recombinant erythropoietin in peritoneal dialysis patients. Adv Perit Dial 2000;16:294-296.
    • (2000) Adv Perit Dial , vol.16 , pp. 294-296
    • Kcomt, J.1    Sotelo, C.2    Raja, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.